Abstract:Autophagy is a conserved lysosomal degradation pathway where cellular components are dynamically degraded and re-processed to maintain physical homeostasis. However, the physiological effect of autophagy appears to be multifaced. On the one hand, autophagy functions as a cytoprotective mechanism, protecting against multiple diseases, especially tumor, cardiovascular disorders, and neurodegenerative and infectious disease. Conversely, autophagy may also play a detrimental role via pro-survival effects on cancer cells or cell-killing effects on normal body cells. During disorder onset and progression, the expression levels of autophagy-related regulators and proteins encoded by autophagy-related genes (ATGs) are abnormally regulated, giving rise to imbalanced autophagy flux. However, the detailed mechanisms and molecular events of this process are quite complex. Epigenetic, including DNA methylation, histone modifications and miRNAs, and post-translational modifications, including ubiquitination, phosphorylation and acetylation, precisely manipulate gene expression and protein function, and are strongly correlated with the occurrence and development of multiple diseases. There is substantial evidence that autophagy-relevant regulators and machineries are subjected to epigenetic and post-translational modulation, resulting in alterations in autophagy levels, which subsequently induces disease or affects the therapeutic effectiveness to agents. In this review, we focus on the regulatory mechanisms mediated by epigenetic and post-translational modifications in disease-related autophagy to unveil potential therapeutic targets. In addition, the effect of autophagy on the therapeutic effectiveness of epigenetic drugs or drugs targeting post-translational modification have also been discussed, providing insights into the combination with autophagy activators or inhibitors in the treatment of clinical diseases.

Mechanistic Insights and Implications of FOXO-SNAI Interplay.

FOXN Transcription Factors: Regulation and Significant Role in Cancer

FOXN Transcription Factors: Regulation and Significant Role in Cancer.

Foxo1 Mediates an Autofeedback Loop Regulating Sirt1 Expression

Toward a mechanistic understanding of DNA binding by forkhead transcription factors and its perturbation by pathogenic mutations

Mechanisms Controlling the Anti-Neoplastic Functions of FoxO Proteins.

The rules and regulatory mechanisms of FOXO3 on inflammation, metabolism, cell death and aging in hosts

From worm to human: bioinformatics approaches to identify FOXO target genes

The Role of Forkhead Box Family in Bone Metabolism and Diseases

The role of FOXO1-mediated autophagy in the regulation of bone formation

FOXF1 Induces Epithelial-Mesenchymal Transition in Colorectal Cancer Metastasis by Transcriptionally Activating SNAI1

FoxO transcription factors in mitochondrial homeostasis

FOXA1 and FOXA2: the regulatory mechanisms and therapeutic implications in cancer

Anti-Neoplastic Activity of the Cytosolic Foxo1 Results from Autophagic Cell Death

FOXM1: Functional Roles of FOXM1 in Non-Malignant Diseases

FOXO3a regulates lipid accumulation and adipocyte inflammation in adipocytes through autophagy

Histone Deacetylase Inhibitors Induce Autophagy Through FOXO1-dependent Pathways.

Epigenetic and post-translational modifications in autophagy: biological functions and therapeutic targets

Integrated Methods Redefine Contrasting Mechanisms Governing Foxp3 Induction and Maintenance

The Regulation of the Autophagic Network and Its Implications for Human Disease

Dynamic FoxO transcription factors